Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Role of phosphoinositide 3-kinase in steroid insensitivity and recurrent bacterial infections in severe asthmatics

EF 2019-20

Résumé
"Asthma is a chronic lung disease that affects 1 in 10 Canadians and is characterized by abnormalities in lung airway structure and function. Eosinophils, a type of white blood cell, is thought to play a significant role in causing the disease and symptoms. Corticosteroids result in a decrease in eosinophils, thereby reducing symptoms, and are mainstay of treatment for majority of asthmatics. However, there are a few patients called 'steroid insensitive,' whose symptoms are not controlled even with high doses of corticosteroids. Additionally, a subset of these steroid insensitive patients also gets repeated chest infections, which are often bacterial. This particular subset of patients is often more symptomatic, and have more emergency room visits and even hospitalizations. At this time, we do not know the underlying mechanism resulting in both steroid insensitivity and recurrent lung infections. We believe that in these patients who get recurring chest infections and also do not respond to corticosteroids may be due to increased activity of a common cellular signaling pathway called phosphoinositide 3-kinase (PI3K). Thus, our research project will study the mechanism of this cellular pathway in hopes of identifying a treatment target. In order to study our aims, we will collect blood and sputum samples from healthy subjects and asthmatics. We will utilize molecular biological techniques developed in our lab and elsewhere to identify key proteins involved in the PI3K pathway. In summary, currently, we do not have any targeted treatment for severe asthmatics who are steroid insensitive and get recurrent bacterial lung infections. Our project aims to investigate the underlying mechanism for this phenomenon with the goal of identifying a treatment strategy."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
428696
Name
Bhalla Anurag
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of phosphoinositide 3-kinase in steroid insensitivity and recurrent bacterial infections in severe asthmatics
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Asthma; Asthma Exacerbations; Bacterial Lung Infections; Biomarkers; Cell Biology; Microrna; Mixed-Granulocytic Inflammation; Phosphoinositide 3-Kinase; Sputum Cell Counts; Steroid Insensitivity
Abstract
"Asthma is a chronic lung disease that affects 1 in 10 Canadians and is characterized by abnormalities in lung airway structure and function. Eosinophils, a type of white blood cell, is thought to play a significant role in causing the disease and symptoms. Corticosteroids result in a decrease in eosinophils, thereby reducing symptoms, and are mainstay of treatment for majority of asthmatics. However, there are a few patients called 'steroid insensitive,' whose symptoms are not controlled even with high doses of corticosteroids. Additionally, a subset of these steroid insensitive patients also gets repeated chest infections, which are often bacterial. This particular subset of patients is often more symptomatic, and have more emergency room visits and even hospitalizations. At this time, we do not know the underlying mechanism resulting in both steroid insensitivity and recurrent lung infections. We believe that in these patients who get recurring chest infections and also do not respond to corticosteroids may be due to increased activity of a common cellular signaling pathway called phosphoinositide 3-kinase (PI3K). Thus, our research project will study the mechanism of this cellular pathway in hopes of identifying a treatment target. In order to study our aims, we will collect blood and sputum samples from healthy subjects and asthmatics. We will utilize molecular biological techniques developed in our lab and elsewhere to identify key proteins involved in the PI3K pathway. In summary, currently, we do not have any targeted treatment for severe asthmatics who are steroid insensitive and get recurrent bacterial lung infections. Our project aims to investigate the underlying mechanism for this phenomenon with the goal of identifying a treatment strategy."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bhalla, Anurag
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~